| Novi M, Lauritano EC, Piscaglia AC, et al.
Portal Vein Tumor Thrombosis Revascularization During Sorafenib Treatment for Hepatocellular Carcinoma. [JOURNAL ARTICLE]
Am J Gastroenterol 2009 Jul; 104(7):1852-1854.
Full Citation |
| Simard JR, Getlik M, Grütter C, et al.
Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors. [JOURNAL ARTICLE]
J Am Chem Soc 2009 Jun 1.
Abstract | Full Citation |
| Frieling T, Heise J, Wassilew SW
Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib. [Journal Article]
Dtsch Med Wochenschr 2009 Jul; 134(28-29):e1-2, 1464.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Daniele B, Di Maio M
Target therapy for hepatocellular carcinoma: is sorafenib for everybody? [Journal Article]
J Clin Gastroenterol 2009 May-Jun; 43(5):389-90.
Full Citation | Find Related Articles |
| Horger M, Lauer UM, Schraml C, et al.
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib. [JOURNAL ARTICLE]
BMC Cancer 2009 Jun 28; 9(1):208.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Lee WJ, Lee JL, Chang SE, et al.
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. [JOURNAL ARTICLE]
Br J Dermatol 2009 May 5.
Abstract | Full Citation | Find Related Articles |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 May; 31(4):263-98.
Abstract | Full Citation |
| Heng DY, Choueiri TK
Non-clear cell renal cancer: features and medical management. [Journal Article]
J Natl Compr Canc Netw 2009 Jun; 7(6):659-65.
Abstract | Full Citation | Find Related Articles |
| Saylor PJ, Michaelson MD
New treatments for renal cell carcinoma: targeted therapies. [Journal Article]
J Natl Compr Canc Netw 2009 Jun; 7(6):645-56.
Abstract | Full Citation | Find Related Articles |
| Brüning A, Burger P, Vogel M, et al.
Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib. [JOURNAL ARTICLE]
Invest New Drugs 2009 Jun 26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
